Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonrotoclax Ramp-up Schedules in Hematological Malignancies
NCT06697184Phase 2Recruiting
- Sponsor
- BeOne Medicines
- Start
- Jan 2025
- Primary completion
- Nov 2029
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of sonrotoclax in chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), sponsored by BeOne Medicines. Started Jan 2025; status: recruiting.
02
Drugs
sonrotoclax
03
Conditions
chronic lymphocytic leukemia (CLL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT06697184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06697184.